Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: Role of mast cells

Pain

Volumn 157, Issue 1, 2016, Pages 80-91

  Iuvone, Teresa ^a   Affaitati, Giannapia ^b   De Filippis, Daniele ^a   Lopopolo, Mariangela ^b   Grassia, Gianluca ^a   Lapenna, Domenico ^b   Negro, Luana ^a   Costantini, Raffaele ^b   Vaia, Massimo ^a   Cipollone, Francesco ^b   Ialenti, Armando ^a   Giamberardino, Maria Adele ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Endometriosis; Mast cells; Rat; Ultramicronized palmitoylethanolamide; Ureteral calculosis; Visceral pain; Viscerovisceral hyperalgesia

Indexed keywords

CHYMASE; NERVE GROWTH FACTOR; PALMIDROL; PLACEBO; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ETHANOLAMINE DERIVATIVE; PALMITIC ACID DERIVATIVE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

AGGRESSION; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DOSE RESPONSE; ENDOMETRIOSIS; FEMALE; HISTOLOGY; HYPERALGESIA; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION; URETER STONE; VISCEROVISCERAL HYPERALGESIA; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CHYMASES; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ETHANOLAMINES; FEMALE; HYPERALGESIA; MAST CELLS; NERVE GROWTH FACTOR; PALMITIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; URETERAL CALCULI; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84951979632     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000220     Document Type: Article

References (70)

1. Albe-Fessard D, Giamberardino MA, Rampin O. Comparisons of different animal models of chronic pain. Adv Pain Res Ther 1990;13:11-27.
2. Aloe L, Leon A, Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 1993;39:145-7.
3. Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noël JC. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril 2006;86:1336-43.
4. Anaf V, El Nakadi I, De Moor V, Chapron C, Pistofidis G, Noel JC. Increased nerve density in deep infiltrating endometriotic nodules. Gynecol Obstet Invest 2011;71:112-17.
5. Anaf V, Simon P, El Nakadi I, Fayt I, Simonart T, Buxant F, Noel JC. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 2002;17:1895-900.
6. Baranowski AP. Chronic pelvic pain. Best Pract Res Clin Gastroenterol 2009;23:593-610.
7. Berkley KJ, Cason A, Jacobs H, Bradshaw HB, Wood E. Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett 2001;306:185-8.
8. Bettoni I, Comelli F, Colombo A, Bonfanti P, Costa B. Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide. CNS Neurol Disord Drug Targets 2013;12:34-44.
9. Bokor A, Kyama CM, Vercruysse L, Fassbender A, Gevaert O, Vodolazkaia A, De Moor B, Fülöp V, D'Hooghe T. Density of small diameter sensory nerve fibres in endometrium: a semi-invasive diagnostic test for minimal to mild endometriosis. Hum Reprod 2009;24:3025-32.
10. Cerrato S, Brazis P, Della Valle MF, Miolo A, Puigdemont A. Effects of palmitoylethanolamideon immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. Vet Immunol Immunopathol 2010;133:9-15.
11. Cobellis L, Castaldi MA, Giordano V, Trabucco E, De Franciscis P, Torella M, Colacurci N. Effectiveness of the association micronized N-palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study. Eur J Obstet Gynecol Reprod Biol 2011;158:82-6.
12. Cocito D, Peci E, Ciaramitaro P, Merola A, Lopiano L. Short-term efficacy of ultramicronized palmitoylethanolamide in peripheral neuropathic pain. Pain Res Treat 2014;2014:854560.
13. Crivellato E, Nico B, Ribatti D. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett 2008;269:1-6.
14. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, Mattace Raso G, Cuzzocrea S, Loverme J, Piomelli D, Meli R, Calignano A. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. Eur J Pharmacol 2009;613:54-9.
15. De Filippis D, D'Amico A, Cinelli MP, Esposito G, Di Marzo V, Iuvone T. Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats. J Cell Mol Med 2009;13:1086-95.
16. De Filippis D, D'Amico A, Cipriano M, Petrosino S, Orlando P, Di Marzo V, Iuvone T. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacol Res 2010;61:321-8.
17. De Filippis D, D'Amico A, Iuvone T. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 2008;20:20-5.
18. De Filippis D, Luongo L, Cipriano M, Palazzo E, Cinelli MP, De Novellis V, Maione S, Iuvone T. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Mol Pain 2011;7:3.
19. De Filippis D, Negro L, Vaia M, Cinelli MP, Iuvone T. New insights in mast cell modulation by palmitoylethanolamide. CNS Neurol Disord Drug Targets 2013;12:78-83.
20. Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol 2012;24:188-93.
21. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 1995;92:3376-80.
22. Ferrero S, Arena E, Morando A, Remorgida V. Prevalence of newly diagnosed endometriosis in women attending the general practitioner. Int J Gynaecol Obstet 2010;110:203-7.
23. Ferrero S, Remorgida V, Venturini PL. Current pharmacotherapy for endometriosis. Expert Opin Pharmacother 2010;11:1123-34.
24. Freitag CM, Miller RJ. Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines? Front Cell Neurosci 2014;8:238.
25. Genovese A, Detoraki A, Granata F, Galdiero MR, Spadaro G, Marone G. Angiogenesis, lymphangiogenesis and atopic dermatitis. Chem Immunol Allergy 2012;96:50-60.
26. Giamberardino MA, Berkley KJ, Affaitati G, Lerza R, Centurione L, Lapenna D, Vecchiet L. Influence of endometriosis on pain behaviors and muscle hyperalgesia induced by a ureteral calculosis in female rats. PAIN 2002;95:247-57.
27. Giamberardino MA, Costantini R, Affaitati G, Fabrizio A, Lapenna D, Tafuri E, Mezzetti A. Viscero-visceral hyperalgesia: characterization in different clinical models. PAIN 2010;151:307-22.
28. Giamberardino MA, De Laurentis S, Affaitati G, Lerza R, Lapenna D, Vecchiet L. Modulation of pain and hyperalgesia from the urinary tract by algogenic conditions of the reproductive organs in women. Neurosci Lett 2001;304:61-4.
29. Giamberardino MA, Tana C, Costantini R. Pain thresholds in women with chronic pelvic pain. Curr Opin Obstet Gynecol 2014;26:253-9.
30. Giamberardino MA, Valente R, De Bigontina P, Vecchiet L. Artificial ureteral calculosis in rats: behavioural characterization of visceral pain episodes and their relationship with referred lumbar muscle hyperalgesia. PAIN 1995;61:459-69.
31. Giugliano E, Cagnazzo E, Soave I, Lo Monte G, Wenger JM, Marci R. The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain. Eur J Obstet Gynecol Reprod Biol 2013;168:209-13.
32. Groothuis PG, Nap AW, Winterhager E, Grümmer R. Vascular development in endometriosis. Angiogenesis 2005;8:147-56.
33. Gylfason JT, Kristjansson AK, Sverrisdottir G, Jonsdottir K, Rafnsson V, Geirsson RT. Pelvic endometriosis diagnosed in an entire nation over 20 years. Am J Epidemiol 2010;172:237-43.
34. Holoch KJ, Lessey BA. Endometriosis and infertility. Clin Obstet Gynecol 2010;53:429-38.
35. Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol 2009;16:540-50.
36. Impellizzeri D, Bruschetta G, Cordaro M, Crupi R, Siracusa R, Esposito E, Cuzzocrea S. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to non-micronized palmitoylethanolamide in a rat model of inflammatory pain. J Neuroinflammation 2014;11:136.
37. Indraccolo U, Barbieri F. Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations. Eur J Obstet Gynecol Reprod Biol 2010;150:76-9.
38. Jarrell J, Ross S, Robert M, Wood S, Tang S, Stephanson K, Giamberardino MA. Prediction of postoperative pain after gynecologic laparoscopy for nonacute pelvic pain. Am J Obstet Gynecol 2014;211:360.e1-8.
39. Konno R, Yamada-Okabe H, Fujiwara H, Uchiide I, Shibahara H, Ohwada M, Ihara T, Sugamata M, Suzuki M. Role of immunoreactions and mast cells in pathogenesis of human endometriosis-morphologic study and gene expression analysis. Hum Cell 2003;16:141-9.
40. Kritas SK, Caraffa A, Antinolfi P, Saggini A, Pantalone A, Rosati M, Tei M, Speziali A, Saggini R, Pandolfi F, Cerulli G, Conti P. Nerve growth factor interactions with mastcells. IntJImmunopathol Pharmacol 2014;27:15-19.
41. Larrivée B, Karsan A. Signaling pathways induced by vascular endothelial growth factor (review). Int J Mol Med 2000;5:447-56.
42. Laschke MW, Giebels C, Menger MD. Vasculogenesis: a new piece of the endometriosis puzzle. Hum Reprod Update 2011;17:628-36.
43. Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 2007;13:331-42.
44. Lopopolo M, Affaitati G, Fabrizio A, Massimini F, Lapenna D, Giamberardino MA, Costantini R. Effects of tramadol on viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis. Fundam Clin Pharmacol 2014;28:331-41.
45. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 2005;67:15-19.
46. Luongo L, Guida F, Boccella S, Bellini G, Gatta L, Rossi F, De Novellis V, Maione S. Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice. CNS Neurol Disord Drug Targets 2013;12:45-54.
47. Mattace Raso G, Russo R, Calignano A, Meli R. Palmitoylethanolamide in CNS health and disease. Pharmacol Res 2014;86:32-41.
48. May K, Becker CM. Endometriosis and angiogenesis. Minerva Ginecol 2008;60:245-54.
49. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A. N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996;300:227-36.
50. McAllister SL, McGinty KA, Resuehr D, Berkley KJ. Endometriosisinduced vaginal hyperalgesia in the rat: role of the ectopic growths and their innervation. PAIN 2009;147:255-64.
51. Mueller MD, Lebovic DI, Garrett E, Taylor RN. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril 2000;74:107-12.
52. Osuga Y, Koga K, Tsutsumi O, Igarashi T, Okagaki R, Takai Y, Matsumi H, Hiroi H, Fujiwara T, Momoeda M, Yano T, Taketani Y. Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis. Am J Reprod Immunol 2000;44:231-5.
53. Petrosino S, Cristino L, Karsak M, Gaffal E, Ueda N, Tüting T, Bisogno T, De Filippis D, D'Amico A, Saturnino C, Orlando P, Zimmer A, Iuvone T, Di Marzo V. Protective role of palmitoylethanolamide in contact allergic dermatitis. Allergy 2010;65:698-711.
54. Petrosino S, Iuvone T, Di Marzo V. N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities. Biochimie 2010;92:724-7.
55. Rocha AL, Reis FM, Taylor RN. Angiogenesis and endometriosis Obstet Gynecol Int 2013;2013:859619.
56. Ross RA, Brockie HC, Pertwee RG. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur J Pharmacol 2000;401:121-30.
57. Scarampella F, Abramo F, Noli C. Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study. Vet Dermatol 2001;12:29-39.
58. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-18.
59. Shu XQ, Mendell LM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci U S A 1999;96:7693-6.
60. Sibert L, Rigaud J, Delavierre D, Labat JJ. Chronic pelvic pain: epidemiology and economic impact. Prog Urol 2010;20:872-85.
61. Skaper SD, Facci L, Fusco M, Della Valle MF, Zusso M, Costa B, Giusti P. Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. Inflammopharmacology 2014;22:79-94.
62. Skaper SD, Facci L, Giusti P. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. Mol Neurobiol 2013;48:340-52.
63. Skaper SD, Pollock M, Facci L. Mast cells differentially express and release active high molecular weight neurotrophins. Brain Res Mol Brain Res 2001;97:177-85.
64. Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update 2011;17:327-46.
65. Sugamata M, Ihara T, Uchiide I. Increase of activated mast cells in endometriosis. Am J Reprod Immunol 2005;53:120-5.
66. Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YG, Ueki M. Vascular endothelial growth factor A and Cgene expression in endometriosis. Hum Pathol 2004;35:1369-75.
67. Vercellini P, Somigliana E, Viganò P, Abbiati A, Barbara G, Fedele L. Chronic pelvic pain in women: etiology, pathogenesis and diagnostic approach. Gynecol Endocrinol 2009;25:149-58.
68. Wang G, Tokushige N, Markham R, Fraser IS. Rich innervation of deep infiltrating endometriosis. Hum Reprod 2009;1:1-8.
69. Wesselmann U, Czakanski PP, Affaitati G, Giamberardino MA. Uterine inflammation as anoxious visceral stimulus: behavioral characterization in the rat. Neurosci Lett 1998;246:73-6.
70. Yunker A, Sathe NA, Reynolds WS, Likis FE, Andrews J. Systematic review of therapies for noncyclic chronic pelvic pain in women. Obstet Gynecol Surv 2012;67:417-25.